investors-2019-new

Investor Overview

We are a global specialty and branded pharmaceutical company, improving the health of patients across the world through our high quality and affordable medicines. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability, positioning us well to maximise the value we create for our business and its diverse stakeholders.

We supply medicines to more than 150 countries and have 70 established business operations in 55 countries. We focus on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets.

INVESTMENT PROPOSITION

Responsible corporate citizen and a trusted partner


Strategically relevant manufacturing capital


Global footprint with a focus on emerging markets

Diverse, branded product portfolio


Committed management team, strongly aligned with shareholders' interests

INVESTOR CALENDAR

November 2019

Publishing of the Integrated Report

14-15 November 2019

SA Tomorrow Conference, New York

5 December 2019

Annual General Meeting

5 March 2020

Interim results announcement for the six months ended 31 December 2019

6 March 2020

Interim results presentation in Cape Town

30 June 2020

Financial year end

10 September 2020

Year end results announcement and presentation in Johannesburg

9 December 2020

Annual General Meeting

SENS ANNOUNCEMENTS

SHARE PRICE CENTRE

View share price information for Aspen Holdings.

SHARE CODE

APN ISIN: ZAE 000066692

JSE data delayed by 15 minutes, page refreshes every 5 minutes. Indicated trade times are actual.

PRESENTATIONS

Aspen's Year End Results presentation for the year ended 30 June 2019
PDF 1.08MB

 

CAPITAL DISTRIBUTIONS

All capital distributions to date

SHAREHOLDER STATISTICS

Analysis of shareholders at 30 June 2018

CORPORATE INFORMATION

All corporate information and contact details

CONTACT DETAILS

Luresha Chetty
+27 31 580 8637
InvestorRelations@aspenpharma.com

WEBCAST

Click here to view the webcast of Aspen's year end results presentation for the year ended 30 June 2019.